Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Das 13-Millionen-Unternehmen mit einer Monster-Entdeckung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 877757 | ISIN: FR0000051732 | Ticker-Symbol: AXI
Frankfurt
14.01.25
21:36 Uhr
0,002 Euro
0,000
0,00 %
1-Jahres-Chart
ATOS SE Chart 1 Jahr
5-Tage-Chart
ATOS SE 5-Tage-Chart
RealtimeGeldBriefZeit
0,0020,00207:48
0,0020,00220.12.24
GlobeNewswire (Europe)
1.239 Leser
Artikel bewerten:
(2)

Atos International: Convening of Atos shareholders and creditors gathered in classes of affected parties to vote on the draft accelerated safeguard plan

Finanznachrichten News

Press release

Convening of Atos shareholders and creditors gathered in classes of affected parties to vote on the draft accelerated safeguard plan

Availability of the draft accelerated safeguard plan

Paris, France - September 6, 2024.

Convening of the classes of affected parties

By judgment of July 23, 2024, the Specialized Commercial Court of Nanterre opened an accelerated safeguard proceedings for the benefit of Atos SE (the "Company"), for an initial period of two months, which may be renewed for two additional months.

As a reminder, the sole objective of the accelerated safeguard proceedings, which only involves financial creditors and shareholders, is to implement and obtain a Court approval on the terms of the financial restructuring plan agreed in the Lock-Up Agreement1, the conclusion of which was announced by the Company in its press release of July 15, 2024. It only relates to the financial indebtedness of Atos (Revolving Credit Facility, Term Loan and bonds) and does not impact suppliers, employees, the governance of the Company, or other claims held by the creditors of the Company or its subsidiaries.

The Specialized Commercial Court of Nanterre appointed SELARL FHBX, represented by Maître Hélène Bourbouloux, and SELARL AJRS, represented by Maître Thibaut Martinat, as judicial administrators with supervisory role.

In this context, the members of the classes of affected parties, Atos shareholders and creditors concerned, are convened to vote on the draft accelerated safeguard plan submitted to them.

The classes of affected parties will thus be able to vote on the draft plan, all in accordance with the specific procedures set out in the internal rules governing the classes of affected parties and the convening notices:

  • either, in the case of creditors concerned, electronically between September 6, 2024 at 12:00 p.m. and September 26, 2024 at 12:00 p.m. (with the votes being recorded on September 27, 2024);
  • or, in the case of shareholders, in person at the meeting of the class of shareholders to be held on Friday, September 27, 2024 at 2 p.m. or by post, by proxy or electronically in accordance with the terms and conditions set out in the notice of meeting serving as the convening notice.

The convening notices, as well as the notice of meeting serving as the convening notice for the shareholders' class, are subject to legal publicity and were published in the bulletin of mandatory legal notices, under the heading Investors, Financial Restructuring.

The classes of affected parties, including the class of shareholders, will vote on a single resolution, namely the approval of the accelerated safeguard plan of Atos.

Availability of the draft accelerated safeguard plan

The draft accelerated safeguard plan, prepared by the Company with the assistance of the judicial administrators, on the basis of which all classes of affected parties will vote, is now available on Atos website, www.atos.net, under the heading Investors, Financial Restructuring, it being specified that this draft accelerated safeguard plan may be amended up to 10 days before the voting date in accordance with applicable legal and regulatory provisions, of which the affected parties will, where applicable, be duly informed.

The results of the votes will be published on Atos website at the end of the vote of the classes of affected parties.

The technical terms and conditions of the equity transactions provided for in the draft accelerated safeguard plan to be submitted to the Specialized Commercial Court of Nanterre for review, and the transactions to be carried out subsequently, are described in further detail in a document available on Atos website, www.atos.net, under the heading Investors, Financial Restructuring.

***

About Atos

Atos is a global leader in digital transformation with c. 92,000 employees and annual revenue of c. €10 billion. European number one in cybersecurity, cloud and high-performance computing, the Group provides tailored end-to-end solutions for all industries in 69 countries. A pioneer in decarbonization services and products, Atos is committed to a secure and decarbonized digital for its clients. Atos is a SE (Societas Europaea), and listed on Euronext Paris.

The purpose of Atosis to help design the future of the information space. Its expertise and services support the development of knowledge, education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Across the world, the Group enables its customers and employees, and members of societies at large to live, work and develop sustainably, in a safe and secure information space.

Contacts

Investor relations: David Pierre-Kahn | investors@atos.net| +33 6 28 51 45 96

Individual shareholders: 0805 65 00 75

Press contact: globalprteam@atos.net


1A Lock-Up Agreement is an agreement under the terms of which the signatories undertake to support and carry out any steps or actions reasonably necessary for the implementation and completion of the Company's financial restructuring. The conclusion of this agreement makes it possible to gather the support of restructuring stakeholders who are not directly involved in the discussions.

Attachment

  • ENG_AtosSE_PressRelease_Convocation_2024-09-06 (https://ml-eu.globenewswire.com/Resource/Download/0fc6c376-69a6-4a6b-bb77-eb9b1e3a067e)

© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.